Drug Discovery (Lead Identification and High Throughput Screening)
Author:
- 15 May 2021
- journal article
- review article
- Published by A and V Publications in Research Journal of Pharmacology and Pharmacodynamics
- Vol. 13 (2) , 46-50
Abstract
In this review we will discuss about the Lead identification, the lead identification is mostly used for the discovery of successful clinical development compound, and it is an essential site for drug discovery. Various important factors that required for discovery a quality leads, such as- Physicochemical, ADME, Biological and PK parameters. These all parameters are required for the identification of high-quality leads. The Combinational chemistry is mostly used for the generation of many compounds in only one process from a mixture. The high throughput screening is suitable for new drug in pharmaceutical industries and it’s mostly used from last two decades.Keywords
This publication has 25 references indexed in Scilit:
- Identification of Nonpeptide CCR5 Receptor Agonists by Structure-based Virtual ScreeningJournal of Medicinal Chemistry, 2007
- Natural Products as Sources of New Drugs over the Last 25 YearsJournal of Natural Products, 2007
- Dependence of Effective Molarity on Linker Length for an Intramolecular Protein−Ligand SystemJournal of the American Chemical Society, 2007
- Improving the hit-to-lead process: data-driven assessment of drug-like and lead-like screening hitsDrug Discovery Today, 2006
- High-Throughput Purification of Single Compounds and LibrariesJournal of Combinatorial Chemistry, 2005
- Virtual Docking Approaches to Protein Kinase B InhibitionJournal of Medicinal Chemistry, 2005
- Selective Optimization of Side Activities: Another Way for Drug DiscoveryJournal of Medicinal Chemistry, 2004
- Molecular Properties That Influence the Oral Bioavailability of Drug CandidatesJournal of Medicinal Chemistry, 2002
- The Design of Leadlike Combinatorial LibrariesAngewandte Chemie International Edition, 1999
- 2-Aryloxymethyl-2,3,5,6-tetrahydro-1,4-oxazines, a new class of antidepressantsJournal of Medicinal Chemistry, 1975